SK HYNIX INC (SKHY)

NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-15

$136.49-6.58%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge SK HYNIX INC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Manage capital expenditures effectively	A supporting condition in SK HYNIX INC's published investment case. The stated target is capex growth <= 10% YoY.	Intact	capex growth exceeds 15% YoY	Capital expenditures: KRW 10,671B FY2026-Q2; GAAP. Published target: capex growth <= 10% YoY. Target and observation units differ. Source published Aug 18, 202610,671,000,000,000 KRW · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain profit margins near 15%	Profit margins are expected to remain healthy as the company invests in R&D and partnerships.	Intact	falls below 12% in FY26	Net margin: 118.28% FY2026-Q2; GAAP. Published target: >=15%. Target period is not explicitly aligned with this observation. Source published Aug 18, 2026118.282551 percent · calculatedSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth to about $358 billion in FY26	Revenue is projected to grow to about $358 billion in FY26.	Intact	falls below $340 billion in FY26	Revenue: KRW 79,318.746B FY2026-Q2; GAAP. Published target: >=358 billion. Target period is not explicitly aligned with this observation. Source published Aug 18, 202679,318,746,000,000 KRW · source valueSource reportLast status assessment Oct 15, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$46698.45

$46348.56 → $46698.45 · observed estimates

FY2027 revenue$516472.27B

$514476.61B → $516472.27B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-28	$46348.56	$514,476,607,501,247	6 / 25
2026-09-29	$46639.71	$517,676,595,825,586	6 / 25
2026-09-30	$46488.57	$515,402,520,929,688	6 / 26
2026-10-01	$46530.09	$516,669,404,105,948	6 / 26
2026-10-02	$46426.64	$515,520,646,004,784	6 / 26
2026-10-03	$46377.43	$515,399,404,130,581	6 / 26
2026-10-04	$46315.78	$514,714,264,155,356	6 / 26
2026-10-05	$46321.49	$514,777,737,729,431	6 / 26
2026-10-06	$46371.81	$515,336,343,354,855	6 / 26
2026-10-07	$46503.48	$515,797,747,908,007	6 / 26
2026-10-08	$46644.57	$516,334,778,762,596	6 / 26
2026-10-09	$46644.57	$516,334,778,762,596	6 / 26
2026-10-10	$46644.57	$516,334,778,762,596	6 / 26
2026-10-11	$46858.87	$519,528,715,070,125	6 / 26
2026-10-12	$46802.65	$518,905,411,038,249	6 / 26
2026-10-13	$46875.41	$519,086,910,025,473	6 / 26
2026-10-14	$46880.33	$518,483,801,790,793	6 / 26
2026-10-15	$46698.45	$516,472,266,485,713	6 / 26

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-07-01	5	1	0
2026-08-01	13	1	0
2026-09-01	14	1	1
2026-10-01	14	1	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 14 Buy / Strong Buy · 1 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 16–Oct 15 · 0 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Wolfe ResearchSep 23 · prior Aug 4

$200.00 → $250.00+25.0%

$0$137.50$275.00

1 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Manage capital expenditures effectivelyCapital expenditures: KRW 10,671B
Maintain profit margins near 15%Net margin: 118.28%
Revenue growth to about $358 billion in FY26Revenue: KRW 79,318.746B

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.2%Typical daily move · historical

Downside history

-34.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

SK HYNIX INC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment represents a speculative growth opportunity. The current thesis state is insufficient due to a lack of recent financial performance history, which makes it difficult to assess the company's trajectory.

What's priced into SK HYNIX INC

The market does not appear to be pricing in significant fragility, as no fragility gates have been triggered. However, the elevated risk suggests that investors are cautious about potential volatility.

What the fundamentals likely do

Fundamentals may face challenges in the near term, given the low probability of missing earnings but the recent history of deep misses in this name and its peers. The elevated risk profile could lead to increased scrutiny of performance.

What SK HYNIX INC hinges on

The long-term thesis hinges on key factors such as potential interest rate cuts by the Fed and the performance of sector bellwethers like NVDA, TSM, and AVGO. Positive signals from these companies could support SKHY, while negative trends could pose risks.

Bottom line

Overall, SKHY's outlook is uncertain with elevated risks, and the investment thesis will require careful monitoring of sector dynamics. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.